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Background: Cardiac resynchronization therapy is an important therapeutic modality in
drug refractory symptomatic patients of heart failure with wide QRS (120 ms) on elec-
trocardiogram. However, wide QRS (considered as a marker of electrical dyssynchrony)
occurs in only 30% of heart failure patients, making majority of drug refractory heart failure
patients ineligible for resynchronization therapy. Significant numbers of patients with
narrow QRS have echocardiographic evidence of left ventricular dyssynchrony. However,
there is sparse data about additional features on the surface ECG which can predict
intraventricular dyssynchrony. This study was undertaken to assess the utility of frag-
mented narrow QRS complex to predict significant intraventricular dyssynchrony in
symptomatic patients of non-ischemic dilated cardiomyopathy.
Method: 100 symptomatic patients of non-ischemic dilated cardiomyopathy with narrow
QRS complexes (50 each with fragmented and normal QRS) were recruited. Tissue Doppler
imaging was used to assess intraventricular dyssynchrony as per ‘Yu index’.
Results: 78% patients (n ¼ 39) in fQRS complex group and 14% (n ¼ 7) in normal QRS complex
group had significant intraventricular dyssynchrony (c2 ¼ 20.61; p < 0.000005). fQRS com-
plexes had 84.78% sensitivity, 79.62% specificity, a positive predictive value of 78% and
negative predictive value of 86% to detect intraventricular dyssynchrony. fQRS also had
sensitivity and specificity of 93% and 90% respectively to localize the dyssynchronous
segment.
Conclusion: fQRS is a marker of electrical dyssynchrony, which results in significant intra-
ventricular dyssynchrony in patients of non-ischemic dilated cardiomyopathy and a nar-
row QRS interval. fQRS localizes the dyssynchronous segment and might be useful in
identifying patients who can benefit from cardiac resynchronization therapy.
Copyright ª 2013, Cardiological Society of India. All rights reserved.iology, Maulana Azad Medical College and G.B. Pant Hospital, Jawaharlal Nehru Marg, New
.co.in, devendra.aiims@gmail.com (D.K. Agrawal).
2013, Cardiological Society of India. All rights reserved.
i n d i a n h e a r t j o u rn a l 6 5 ( 2 0 1 3 ) 1 7 2e1 7 9 1731. Introduction 2. MethodsCardiac resynchronization therapy (CRT) is a useful thera-
peutic strategy in drug refractory symptomatic patients of
heart failure (HF) with wide QRS (120 ms) on electrocardio-
gram (ECG).1 Though QRS duration 120 ms has been adopted
as a marker of electrical dyssynchrony responsible for pres-
ence of left ventricular (LV) dyssynchrony and subsequent
eligibility for CRT, studies suggest that QRS widening120 ms
occurs in only 30% of HF patients.2,3 In patients of HF with
normal QRS duration, LV dyssynchrony has been reported in
20e50% patients.4e7 However, there are not enough studies
available analyzing additional features on the surface ECG that
can be taken as marker of electrical dyssynchrony resulting in
significant intraventricular dyssynchrony (IVD) in patients of
HF with narrow QRS. Till date only two studies have reported
that fQRS on the surface ECG is a predictor of significant IVD in
patients of non-ischemic DCM.8,9 We undertook this study to
assess the sensitivity, specificity and positive predictive value
(PPV) of fQRS complex on the surface ECG to detect significant
IVD in symptomatic patients of non-ischemic DCM.Table 1 e Demographic, clinical, electrocardiographic and basi
Fragmented QRS (n ¼ 50)
Age (in years) 45.88  13.70
Sex (M:F) 32:28
NYHA CLASS (II:III-IV) 27:23
Beta blocker use n (%) 45 (90%)
ACE-inhibitor use n (%) 43 (86%)
Digoxin n (%) 45 (90%)
Heart rate (BPM) 93.08  17.21
PR interval (ms) 150.18  29.78
QRS duration (ms) 99.42  13.05
LVEDD (mm) 62.42  8.10
LVESD (mm) 54.1  7.85
LVEF % (Simpson’s) 22.24  5.08
EPSS (mm) 20.66  3.14
MR regurgitant volume (ml) 31.39  15.72
TR jet gradient (mm Hg) 28.04  9.05
Mitral E/A 2.45  1.47
IVRT (ms) 97.92  23.04
Septal s (cm/sec) 2.88  0.77
Septal e (cm/sec) 2.98  1.09
Septal a (cm/sec) 3.81  1.01
Lateral s (cm/sec) 2.85  0.76
Lateral e (cm/sec) 4.96  1.72
Lateral a (cm/sec) 3.12  1.00
E/e septal 33.69  17.69
E/e lateral 21.70  15.24
SPWD (ms) 87.94  64.22
RVOT PEP (ms) 96.76  19.65
Aortic PEP (ms) 111.96  21.32
Aortic e RVOT PEP (ms) 15.2  14.46
Data are as mean  SD for continuous variable and absolute no. (%) for ca
late diastolic velocity; ACE-angiotensin converting enzyme; E-Early diasto
early diastolic velocity; IVRT-Iso-volumetric relaxation time; LVEDD-Le
fraction; LVESD-Left ventricular end-systolic diameter; MR-Mitral regurg
PEP-Pre ejection period; RVOT-Right ventricular outflow tract; s-Tissue Do
TR-Tricuspid regurgitation. *Statistically significant difference in values b2.1. Patients selection
This study was conducted in GB Pant Hospital, New Delhi, a
tertiary care centre, located in the Northern part of India. The
study protocol conforms to the ethical guidelines of the 1975
Declaration of Helsinki as reflected in a priori approval by the
institution’s human research committee.
A total of 100 patients of chronic HF due to non-ischemic
dilated cardiomyopathy (DCM), with LV ejection fraction of
less than 35% and sinus rhythm having narrow QRS com-
plexes (<120 ms), were prospectively recruited. These
included 50 patients with fQRS complexes and another 50
without fragmentation of QRS complexes. All patients
included in the study had LV dysfunction of at least 2 years
and were symptomatic (New York Functional Class II or
above) in spite of optimal medical therapy for at least 6
months (Table 1). The patients were evaluated carefully for
their functional capacities and 12 lead ECGs were obtained.
Coronary angiogram was done in all patients to rule out thec echocardiographic parameters.
Normal QRS (n ¼ 50) Chi square value p value
47.84  14.07 0.48
28:22 0.33 0.56
36:14 4.45 0.22
42 (84%) 0.40 0.53
45 (90%) 0.19 0.66
43 (86%) 0.19 0.66
92.32  21.28 0.84
143.90  29.88 0.30
90.10  13.75 <0.001*
60.68  8.01 0.28
51.80  7.32 0.13
24.24  5.92 0.07
20.09  3.02 0.36
31.95  15.11 0.86
29.09  10.13 0.61
2.13  1.24 0.23
79.98  18.91 <0.05*
2.71  0.71 0.25
3.13  1.06 0.51
3.94  0.97 0.50
2.78  0.75 0.62
4.68  1.79 0.42
3.14  1.01 0.92
30.13  15.81 0.29
21.72  14.05 0.99
100.58  67.33 0.34
98.60  18.03 0.63
113.32  19.54 0.74
14.72  11.25 0.85
tegorical variable; A-Late diastolic velocity; a-Tissue Doppler imaging
lic velocity; EPSS-E point septal separation; e-Tissue Doppler imaging
ft ventricular end-diastolic diameter; LVEF-Left ventricular ejection
itation; NYHA-New York Heart Association functional classification;
ppler imaging systolic velocity; SPWD-Septal to posterior wall delay;
etween two groups.
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nary artery) coronary artery disease (CAD). Patients with
organic valvular heart disease, history suggestive of CAD,
atrial fibrillation, kidney failure, liver failure and on perma-
nent pacemakers were excluded from the study. The study
protocol was approved by the institutional review board.
Written informed consent was obtained from all participants.2.2. ECG
The resting 12-lead ECG (filter range, 0.05e100 Hz; A.C. filter,
60 Hz, 25 mm/s, 10 mm/mV) was analyzed by two indepen-
dent clinicians who were blinded to echocardiographic data.
The fQRS included various RSR’ patterns and was defined by
the presence of an additional R-wave (R0 prime), notching in
nadir of the S-wave, notching of R-wave, or the presence of
more than one R prime (fragmentation) in two contiguous
leads corresponding to a major myocardial segment as pre-
viously described by Das et al (Fig. 1).10 The presence of fQRS in
2 contiguous anterior leads (V1eV5) were assigned to ante-
rior myocardial segments, in 2 contiguous lateral leads (I,
aVL, and V5, V6) to the lateral myocardial segments, in 2
contiguous inferior leads (II, III, and aVF) to the inferior
myocardial segments and in both V1 and V2 only to the pos-
terior myocardial segments.2.3. Echocardiography
Standard echocardiography with Doppler studies was per-
formed by using a commercially available system (Philips iE33
system, Andover, Massachusetts, USA). LV dimensions were
measured by two-dimensional guided M-mode echocardiog-
raphy according to the guidelines of the American Society of
Echocardiography.11 LV volumes were determined by the use
of biplane Simpson’s method of disks, and the ejection frac-
tion was calculated with a formula calling for the subtraction
of the end-systolic volume from the end-diastolic volume and
the difference divided by the end-diastolic volume. The
effective orifice area and the regurgitant volume of the func-
tional mitral regurgitation jet (MR volume) were calculated by
‘proximal iso-velocity surface area’ method.12
Tissue Doppler imaging (TDI) was performed in the apical
views (four-chamber, two-chamber and long-axis) for the long
axis motion of the left ventricle. Two-dimensional echocar-
diography with tissue Doppler color imaging was performed
with a 2.5 MHz phase array transducer. Myocardial regional
velocity curves were constructed from the digitized images as
previously described13 (Fig. 2B). In this way septal, ante-
roseptal, anterior, lateral, inferior and posterior segmentsFig. 1 e Various morphologies of QRS on 12-lead ECG
defined as fQRS in present study originally proposed by
Das et al.10were interrogated at both basal and middle levels. Aortic
opening and closure were determined by sampling the flow
through the LV outflow tract with the use of pulsed Doppler
echocardiography. For the purpose of measurement, the
beginning of the QRS complex was used as the reference
point, from where the time to peak myocardial sustained
systolic (Ts) and early diastolic (Te) velocities were calculated.
The higher peak in velocity was selected when double peaks
were encountered within the aortic ejection period.
To assess global LV function, the myocardial sustained
systolic (s), early diastolic (e) and late diastolic (a) velocities
from the basal septal and basal lateral segments were calcu-
lated. For the assessment of synchronicity, the standard de-
viations of Ts (Ts-SD) of all 12 LV segments were calculated.
Significant systolic IVD was defined as Ts-SD >32.6 ms pro-
posed by Yu et al and popularly known as ‘Yu index’.14 Fig. 2B
depicts color coded TDI (post processing image) of a patient
with the ECG shown in Fig. 2A, showing systolic dyssynchro-
nous inferior wall segments.
We also looked for the association of fQRS and the most
delayed contracting LV segment on echocardiography. ‘Dys-
synchronic segments’ were defined as those LV segments that
contracted later than 100ms following the earliest contracting
LV segment (which had the earliest Ts) and ‘most delayed
segment’ was the last contractingmyocardial segment (which
had the latest Ts).
2.4. Statistical analysis
Analysis was performed using a statistical software program
(SPSS for windows, version 17.0, SPSS Inc. Chicago, IL, USA).
Data has been presented as mean  SD and compared using
the paired student’s t test. ManneWhitney U test has been
used when the distribution was not normal. Categorical data
between two or more groups were compared by Pearson c2
test. P value of <0.05 was considered to be significant. Sensi-
tivity was defined by the number of true positives for the
presence of fQRS complexes and IVD, both. Specificity was
defined by the number of true negatives with no fQRS com-
plexes and the absence of dyssynchrony. Intra-observer (the
mean difference between two independent measurements)
and inter-observer (the mean difference between 2 indepen-
dent observers) variabilities were analyzed in 10 randomly
selected patients and expressed as the mean percent error
(difference divided by number of observations).3. Results
The overall study group comprised of 40 women (40%) and
60 men (60%), with mean (SD) age of 46.86  13.85 years. The
estimated inter-and intra-observer variabilities for fragmen-
tation in ECG were 2.5% and 1.8% and for TDI measurements
on echocardiography were 4.8% and 3.1%, respectively. The
demographic, clinical, electrocardiographic and echocardio-
graphic features of patients with fragmented or normal QRS
complexes have been shown in Tables 1 and 2. The two groups
were well matched with respect to age, sex, New York Heart
Association (NYHA) functional class and use of drugs like beta
blockers, ACE-inhibitor, diuretics and digoxin. There was no
Fig. 2 e (A): 12-lead ECG showing fragmented narrow QRS complexes in inferior leads (B): Colour coded TDI (post processing
image) of the same patient showing systolic dyssynchronous inferior wall segments.
Table 2 e Comparison of time to peak myocardial sustained systolic velocity (Ts) (in ms) between patients with fQRS and
without fQRS.
Segment Fragmented QRS (n ¼ 50) Normal QRS (n ¼ 50) p value
Basal septal 158.52  37.86 160.26  33.09 0.80
Mid septal 156.24  37.56 160.80  33.75 0.52
Basal lateral 177.28  49.88 164.88  34.25 0.15
Mid lateral 182.18  49.23 164.16  32.79 0.03*
Basal inferior 187.48  48.44 169.64  32.64 0.03*
Mid inferior 188.18  47.05 169.08  29.24 0.01*
Basal anterior 177  47.21 161.36  28.38 0.048*
Mid anterior 183.24  50.14 162.18  29.55 0.01*
Basal posterior 172.16  40.25 167.08  29.08 0.47
Mid posterior 173.76  45.23 169.84  31.05 0.61
Basal anteroseptal 170.04  37.11 162.94  26.94 0.27
Mid anteroseptal 169.7  38.52 169.90  34.23 0.98
Ts-SD (Yu index) 35.64  12.79 20.45  11.17 <0.001*
Yu index positive patient n (%) 39 (78%) 7 (14%) 0.000005*
Data are as mean  SD; Ts Max- Time to peak systolic velocity for the most delayed segment; Ts-SD- Standard deviation of all 12 Ts values.
*Statistically significant difference in values between two groups.
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fraction and mitral regurgitation between the two groups.
However, there was significant difference in the QRS
duration in patients with fQRS complexes as compared to
those with normal QRS, though QRS duration in both the
groups was <120 ms (99.42  13.05 ms vs. 90.10  13.75 ms;
p < 0.001).
In the 50 patients with fQRS complex, the distribution of
fragmentation was as follows; inferior segment in 18 (36%),
anterior in 12 (24%) and lateral in 10 (20%). The fQRS was seen
inmore than onemyocardial segment in 10 (20%) patients and
the distribution of fragmentation was as follows: inferior and
lateral segments in 5 (10%), anterior and inferior in 4 (8%), and
anterior and lateral in one patient (2%).
Table 2 shows the regional Ts in individual LV segments
and it was significantly delayed in some LV segments in fQRS
group compared to normal QRS group. Significant systolic IVD
(‘Yu index’ Ts-SD > 32.6 ms) was seen in 39 patients (78%) in
fQRS complex group and 7 patients (14%) in normal QRS
complex group (Pearson’s c2 ¼ 20.61; p < 0.000005) [Table 2].
The presence of fQRS complexes in the basal ECG was
found to detect systolic IVD as defined by the ‘Yu index’ (Ts-
SD > 32.6 ms) with sensitivity of 84.78%, specificity of 79.62%,
positive predictive value (PPV) of 78% and a negative predic-
tive value (NPV) of 86% (Table 3).
The 50 patients with fQRS complexes were sub-divided
into two groups with either significant systolic dyssyn-
chrony (group 1, n ¼ 39) or without dyssynchrony (group 2,
n ¼ 11) on the basis of Ts-SD greater than or lesser than
32.6 ms. Table 4 shows the clinical, demographic and echo-
cardiographic characteristics of patients in group 1 and 2. The
demographic and clinical parameters between the two groups
were not statistically different. The patients in group 1 had
significantly longer isovolumetric relaxation time (IVRT) in
comparison to patients in group 2 (105.23  20.36 vs.
72.00 8.90ms; p< 0.001). There was no significant difference
in any other echocardiographic parameters between the two
groups. Among 39 patients of group 1 with significant systolic
dyssynchrony, 30 (76.92%) patients had ECG fragmentation in
themaximal dyssynchronic segment and six (15.39%) patients
had ECG fragmentation in one of the dyssynchronic segments.
In three (7.69%) patients, fragmented segments and dys-
synchronic segments did not correlate. Among the dys-
synchronic patients, the sensitivity and specificity of a
fragmented segment on ECG to detect themost dyssynchronic
segment or one of the dyssynchronic segments were 93% and











Fragmented QRS 39 (true positives) 11 (false positives) 50
Normal QRS 7 (false negatives) 43 (true negatives) 50
Total 46 54 1004. Discussion
CRT is an established treatment option for patients with drug
refractory heart failure. The predominantmechanismof benefit
from CRT appears to be related to the presence of IVD due to
electrical conduction delay and subsequent resynchronization
after CRT.15e19 The presence of significant IVD at baseline sec-
ondary to electrical dyssynchrony is therefore, mandatory for
the response to CRT. QRSduration of120mshas been adopted
as a cut-off point for electrical dyssynchrony resulting in LV
systolic dyssynchrony in CRT trials20,21 and subsequently by
treatment guidelines.1 However, studies suggest that QRS
widening of 120 ms occurs in only 30% of HF patients making
majority of HF patients ineligible for CRT. On the other hand,
significant IVD by TDI has been reported in 36e51%14,22 of pa-
tientswithHFandQRS<120ms, and thesepatients also showed
benefit from CRT.23,24 Similar prevalence of IVD has also
emerged from strain imaging25 and radionuclide phase anal-
ysis.26 The aim of our study was to see whether fQRS on the
surfaceECGcouldbeusedasamarkerofelectricaldyssynchrony
to predict the presence of significant IVD and refer the patients
accordingly for subsequent echocardiographic assessment.
Das et al10 first reported the significance of fQRS in patients
of CAD where he showed it to be a better predictor of
myocardial scar than Qwaves on ECG, in patients with narrow
QRS complexes. fQRS in CAD patients occurs due to heterog-
enous ventricular activation caused by ischemia and
myocardial scars. In non-ischemic DCM, inflammation, myo-
cyte necrosis and fibrosis27,28 lead to uncoordinated depolar-
ization of viablemyocyte groups surrounded by fibrotic tissue,
which is manifested on the surface ECG as fQRS and eventu-
ally lead to mechanical dyssynchrony.
Tigen et al, were the first to investigate the relationship
between fQRS and IVD in patients of non-ischemic DCM and
narrow QRS interval (duration <120 ms).8 In this study, sig-
nificant systolic dyssynchrony was defined as the maximum
difference in sustained systolic velocities between any two LV
segments of more than 100ms. Using this criteria, fQRS on the
surface ECG was found to detect IVD in 72.5% patients (n ¼ 40)
with sensitivity of 90.6% and positive predictive value of
72.5%. Subsequently, in a small study, Basaran et al9 reported
that fQRS complexes on the surface ECG in patients of non-
ischemic DCM were associated with significant IVD in 76%
patients (n ¼ 25) as assessed by the ‘Yu index’ (Ts-SD
>32.6 ms). But due to lack of control group of patients without
fQRS, they could not assess the sensitivity or PPV of fQRS on
ECG to predict significant IVD as assessed by the Yu index.
The ‘Yu index’ has been shown to be an excellent predictor
of response to CRT therapy defined by reverse remodeling
(15% reduction in LV end-systolic volume). In patients with
QRS duration >150 ms, the ‘Yu index’ has a sensitivity and
specificity of 100% and 78%, respectively to predict reverse
remodeling, while in patients with QRS duration of
120e150 ms the sensitivity is 83% and specificity is 86%.30 So
we decided to use ‘Yu index’ to assess mechanical dyssyn-
chrony in patientswith fQRS and drug refractory symptomatic
non-ischemic dilated cardiomyopathy as it may also serve as
a predictor of response to CRT in this subgroup of patients
with narrow QRS. Yu et al14 developed this twelve segment
Table 4 e Characteristics of patients with fQRS with (group 1) and without (group 2) significant systolic dyssynchrony.
Characteristic Group 1 (with systolic
dyssynchrony) (n ¼ 39)
Group 2 (no systolic
dyssynchrony) (n ¼ 11)
Chi square value p value
Age (in years) 46.13  14.24 45.00  12.20 0.80
Sex (M:F) 23:16 9:2 0.43 0.51
NYHA class n (%) 2.74 0.09
II 23 (59%) 4 (57%)
III-IV 16 (41%) 7 (43%)
Heart rate (BPM) 91.67  17.74 98.09  14.91 0.24
PR interval (ms) 148.59  29.52 155.82  31.49 0.51
QRS duration (ms) 99.08  13.32 100.64  12.62 0.72
LVEF % (Simpson’s) 22.31  5.30 22.00  4.43 0.85
EPSS (mm) 20.47  3.44 21.33  1.70 0.26
MR regurgitant volume (ml) 31.61  13.45 30.66  22.41 0.90
TR jet gradient (mm Hg) 27.09  9.40 31.10  7.46 0.18
Mitral E/A 2.29  1.39 3.03  1.70 0.21
IVRT (ms) 105.23  20.36 72.00  8.90 <0.001*
Septal s (cm/sec) 2.87  0.81 2.93  0.65 0.81
Septal e (cm/sec) 2.99  1.12 2.97  1.04 0.97
Septal a (cm/sec) 3.84  0.96 3.69  1.21 0.71
Lateral s (cm/sec) 2.94  0.81 2.55  0.48 0.06
Lateral e (cm/sec) 5.01  1.59 4.71  2.05 0.66
Lateral a (cm/sec) 3.21  0.98 2.81  1.05 0.27
E/e septal 32.46  16.97 38.08  20.32 0.42
E/e lateral 20.28  14.43 27.05  17.68 0.26
Ts-SD (ms) 41.67  5.96 14.25  4.63 <0.001*
Data are as mean  SD for continuous variable and absolute no. (%) for categorical variable; A-Late diastolic velocity; a-Tissue Doppler imaging
late diastolic velocity; E-Early diastolic velocity; EPSS-E point septal separation; e-Tissue Doppler imaging early diastolic velocity; IVRT-
Isovolumetric relaxation time; LVEF-Left ventricular ejection fraction; MR-Mitral regurgitation; NYHA-New York Heart Association functional
classification; s-Tissue Doppler imaging systolic velocity; TR-Tricuspid regurgitation; Ts-SD-Standard deviation of time to peak systolic velocity
of 12 LV segments. *Statistically significant difference in values between two groups.
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three apical views (four-chamber, two-chamber and apical
long axis view). In contrast to the simple two segment (apical
four-chamber view to detect basal septal-lateral delay) and
four segment (basal segments of septal, lateral, inferior and
anterior walls) approaches to detect IVD, this 12 segment
model also includes the anterior septum and posterior walls
which often have dyssynchrony. The mechanical dyssyn-
chrony index is derived by calculating the standard deviation
of the time to peak systolic velocity in the ejection phase in the
12 segments and a cut-off value of >32.6 ms has been derived
to define significant IVD. We used the color coded TDI to
assess IVD as this has been recommended as ‘the preferred
approach’ by the American Society of Echocardiography
Dyssynchrony Writing Group.29 To the best of our knowledge,
this is the first study to show that fQRS on the surface ECG has
a sensitivity of 84.78% and a PPV of 78% to detect significant
IVD as defined by the ‘Yu index’.
We also found that fQRS complexes indicated either the
most delayed segment or one of the dyssynchronous segment
with a sensitivity and specificity of 93% and 90% respectively.
This can guide the echocardiographer in localizing the dys-
synchronous LV segment on TDI. Further it may also help in
planning the site of LV lead position during CRT.
Arandomizedcontrolledtrial,RethinQ31 investigatedtherole
of CRT in HF patients with narrow QRS and echocardiographic
evidence of IVD. In the absence of ECG evidence of electrical
dyssynchrony, IVD per se failed to provide clinical benefits with
CRT over medial therapy. As our study has shown that fQRS onthe surface ECG is a marker of electrical dyssynchrony and can
predict significant IVD as defined by the ‘Yu index’ inmore than
80%patients, itmay also serve as a predictor of response to CRT
in this sub-group of HF patients with narrow QRS.
In our study, QRS duration was significantly greater in pa-
tients with fQRS complexes as compared to those without
fragmentation, although both groups had QRS duration of
<120 ms. As fragmentation along with widening of QRS, leads
to electrical dyssynchrony, fQRS in patients with QRS<120 ms
maybeconsidered tohave thesamesignificanceaswideQRSto
predict the presence of electrical dyssynchrony leading to IVD
and responsiveness to CRT in patients of non-ischemic DCM.
4.1. Study limitations
We used the ‘Yu index’ to assess IVD. The PROSPECT study32
has, however, shown that the 12 segment TDI model had
inter-observer and intra-observer variability of 34% and 11%
respectively, limiting the reproducibility of the technique.
Studies with newer techniques like tissue synchronization,
real time 3D echocardiography and speckle tracking for pre-
dicting IVD in patients with fragmented narrow QRS com-
plexes, should be undertaken.5. Conclusion
Fragmentation of QRS complex on ECG is an important pre-
dictor of electrical dyssynchrony resulting in significant IVD in
i n d i a n h e a r t j o u r n a l 6 5 ( 2 0 1 3 ) 1 7 2e1 7 9178patients with non-ischemic DCM and a narrow QRS interval.
fQRS on the surface ECG is also helpful for localizing the
dyssynchronous segment. In future, studies are needed to
assess the beneficial effects of CRT in drug refractory, symp-
tomatic HF patients with narrow fragmented QRS complexes
and significant IVD.Conflicts of interest
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